A federal health agency’s policy limiting certain hospitals from using their group purchasing arrangements to buy medicines outside of a drug discount program is contrary to law, according to lawsuit filed by
The Health Resources and Services Administration acted unlawfully when it denied Premier’s request to exempt it from a 2013 policy that limits when hospitals under the 340B Drug Discount Program can use their group purchasing arrangements to buy non-340B drugs, according to the health-care company’s complaint filed Nov. 1 in the US District Court for the District of Columbia.
Under the federal 340B program, covered ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.